CJC-1295 No DAC + Ipamorelin (10mg)

CJC-1295 No DAC + Ipamorelin — Growth Hormone Synergy Research Blend
CJC-1295 No DAC + Ipamorelin combines a GHRH analog with a selective ghrelin receptor agonist to provide complementary stimulation of endogenous growth hormone release pathways.
Mechanism Of Action
CJC-1295 No DAC activates GHRH receptors while Ipamorelin selectively targets ghrelin receptors. Together, these pathways create a synergistic increase in growth hormone signaling studied extensively in endocrine research.
Research Applications
Growth hormone synergy studies
IGF-1 pathway investigations
Metabolic regulation research
Endocrine function analysis
Peptide interaction studies
Product Specifications
Quantity: Varied per vial
Purity: ≥99% (HPLC verified)
Form: Lyophilized powder
Storage: Refrigerate after reconstitution
Testing: USA lab tested, COA available
For research purposes only. Not for human use or consumption.